Swiss biotech Melodia sings $275M song for Alivexis’ preclinical cathepsin C inhibitor

Swiss biotech Melodia sings $275M song for Alivexis’ preclinical cathepsin C inhibitor jwaldron Fri, 06/21/2024 - 05:08